Omeros (OMER) receives FDA approval for Yartemlea (narsoplimab) in TA-TMA, driving shares up nearly 80% to a $1bn+ valuation.
SmartAsset on MSN
Is a $400k pension lump sum or $2,000 monthly the better choice?
Deciding whether to take a $400,000 lump sum or monthly pension benefit of $2,000 requires calculating the relative value of each option. Generally speaking, the sooner you can receive the lump sum, ...
The Daily Overview on MSN
Powerball's $1.6B jackpot won't make you a billionaire, here's why
The headline number on a record lottery drawing is designed to dazzle, but it does not reflect what a winner can actually spend. A $1.6 billion Powerball jackpot sounds like instant billionaire status ...
The Tribunal held that excess stock found during survey, when arising from regular business activity and disclosed in accounts, cannot be taxed as unexplained investment under Section ...
The Kraft Heinz Company has appointed Steve Cahillane as its next CEO effective January 1, 2026, and as future CEO of the planned Global Taste Elevation Co., while Carlos Abrams-Rivera will step down ...
TriNet and Capgemini are spotlighted as outsourcing demand rises, fueled by cost efficiency, cybersecurity needs and rapid adoption of AI-driven services.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results